As of March 2024 Heron Therapeutics has a market cap of $0.41 Billion. This makes Heron Therapeutics the world's 6214th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.41 B | 63.22% |
2023 | $0.25 B | -14.16% |
2022 | $0.29 B | -68.06% |
2021 | $0.93 B | -51.84% |
2020 | $1.93 B | -8.93% |
2019 | $2.12 B | 4.65% |
2018 | $2.02 B | 74.56% |
2017 | $1.16 B | 126.29% |
2016 | $0.51 B | -46.75% |
2015 | $0.96 B | 227.88% |
2014 | $0.29 B | 40.15% |
2013 | $0.20 B | 27.36% |
2012 | $0.16 B | 258.05% |
2011 | $46 M | 153.99% |
2010 | $18.11 M | -64% |
2009 | $50.31 M | 287.2% |
2008 | $12.99 M | -73.29% |
2007 | $48.65 M | 39.6% |
2006 | $34.85 M | -9.9% |
2005 | $38.67 M | -6.36% |
2004 | $41.3 M | -18.32% |
2003 | $50.57 M | 147.09% |
2002 | $20.46 M | -64.09% |
2001 | $56.99 M |
On Mar 28th, 2024 the market cap of Heron Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
SurModics SRDX | $0.41 B | 0.31% | ๐บ๐ธ USA |
Pacira Biosciences
PCRX | $1.35 B | 226.30% | ๐บ๐ธ USA |
Ligand Pharmaceuticals LGND | $1.29 B | 210.81% | ๐บ๐ธ USA |
Alkermes ALKS | $4.52 B | 986.13% | ๐ฎ๐ช Ireland |
Nektar Therapeutics
NKTR | $0.17 B | -58.81% | ๐บ๐ธ USA |